By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Conditions A-Z > Gastrointestinal > Peptic Ulcer Disease

Peptic Ulcer Disease

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
17 Min Read
SHARE
11 min read|2,162 words

Peptic Ulcer Disease

What is Peptic Ulcer Disease?

Peptic ulcer disease is a condition characterized by open sores that develop in the lining of the stomach, small intestine, or esophagus. These ulcers form when the protective mucus layer is weakened, allowing stomach acid to damage the underlying tissue. The condition affects approximately 10% of people worldwide at some point in their lives, with equal prevalence between men and women. While once thought to be caused primarily by stress and spicy foods, medical research has shown that most peptic ulcers result from bacterial infection or certain medications.

Key statistics

Global prevalence 4-10% of population
Annual incidence 0.3-1.9% per year
Mortality rate Less than 1% when treated
Peak age of onset 30-60 years old

Symptoms

Common symptoms include: burning stomach pain, bloating, heartburn, nausea, vomiting, loss of appetite, unintended weight loss, and dark or bloody stools.

The most characteristic symptom is a burning or gnawing pain in the upper abdomen, typically between the breastbone and navel. This pain often occurs when the stomach is empty, such as between meals or during the night, and may be temporarily relieved by eating certain foods or taking antacids. Some patients experience bloating and feeling full after eating small amounts. Nausea and vomiting may occur, particularly if the ulcer interferes with normal digestion. More serious symptoms include vomiting blood (which may appear bright red or dark like coffee grounds), passing dark or tarry stools, and severe abdominal pain that suddenly worsens. Some people with peptic ulcers experience no symptoms at all, particularly those taking nonsteroidal anti-inflammatory drugs regularly.

Causes and risk factors

The primary causes of peptic ulcer disease are infection with Helicobacter pylori bacteria (responsible for 60-70% of duodenal ulcers and 60% of gastric ulcers) and regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, aspirin, and naproxen. H. pylori bacteria weaken the protective mucus coating of the stomach and duodenum, allowing acid to penetrate and damage the sensitive tissue beneath.

Submit Your Paper
GMJ_Submit_Banner

Risk factors include prolonged NSAID use, family history of peptic ulcers, smoking tobacco, excessive alcohol consumption, and psychological stress. Certain medical conditions increase risk, including Zollinger-Ellison syndrome, Crohn’s disease, and liver, kidney, or lung disease. Age over 50, particularly when combined with NSAID use, significantly increases risk. Contrary to popular belief, spicy foods and stress alone do not cause ulcers, though they may worsen symptoms in existing ulcers.

Prevention

Prevention strategies focus on reducing exposure to known risk factors. Avoiding unnecessary NSAID use or taking the lowest effective dose for the shortest time possible significantly reduces ulcer risk. When long-term NSAID therapy is necessary, doctors may prescribe protective medications such as proton pump inhibitors. Smoking cessation and limiting alcohol consumption are important preventive measures. While H. pylori eradication therapy can prevent recurrent ulcers in infected individuals, routine screening of asymptomatic people is not recommended. Maintaining good hygiene, including regular handwashing, may help prevent H. pylori transmission, though the exact mode of transmission remains unclear. Managing stress through healthy coping mechanisms and maintaining a balanced diet rich in fruits, vegetables, and fiber may support overall digestive health.

Complications

Untreated peptic ulcers can lead to serious, potentially life-threatening complications. Bleeding occurs in approximately 15-20% of cases and represents the most common complication, ranging from slow, chronic bleeding causing anemia to severe hemorrhaging requiring emergency treatment. Perforation, where the ulcer creates a hole through the stomach or intestinal wall, occurs in 2-10% of cases and constitutes a medical emergency requiring immediate surgical intervention.

Gastric outlet obstruction may develop when ulcers cause swelling or scarring that blocks the passage of food from the stomach to the small intestine, occurring in about 2% of cases. This complication typically requires surgical correction. Penetration occurs when an ulcer burrows through the stomach or duodenal wall into adjacent organs such as the pancreas, liver, or bile duct. Long-term complications may include chronic pain, recurrent bleeding, and in rare cases involving gastric ulcers, an increased risk of stomach cancer, particularly in those with H. pylori infection.

Diagnosis

Diagnosis begins with a thorough medical history and physical examination, focusing on symptom patterns, medication use, and risk factors. Laboratory tests include testing for H. pylori through blood antibody tests, stool antigen tests, or urea breath tests, with the breath test being most accurate for detecting active infection.

Upper endoscopy represents the gold standard for diagnosis, allowing direct visualization of the stomach and duodenal lining and enabling biopsy collection if necessary. This procedure involves inserting a thin, flexible tube with a camera through the mouth to examine the digestive tract. Upper gastrointestinal series (barium swallow X-rays) may be used when endoscopy is not feasible, though it’s less sensitive for detecting small ulcers. Complete blood count may reveal anemia from chronic bleeding, and stool tests can detect hidden blood. In cases of suspected complications, CT scans may be performed to evaluate for perforation or other serious complications.

Treatment

Treatment depends primarily on the underlying cause. For H. pylori-positive ulcers, triple or quadruple antibiotic therapy is standard, typically including clarithromycin, amoxicillin or metronidazole, and a proton pump inhibitor such as omeprazole or lansoprazole for 10-14 days.

Acid suppression therapy forms the cornerstone of treatment for all peptic ulcers. Proton pump inhibitors are most effective, typically prescribed for 4-8 weeks for duodenal ulcers and 8-12 weeks for gastric ulcers. H2 receptor antagonists like ranitidine or famotidine represent alternative options. For NSAID-related ulcers, discontinuing the offending medication when possible is crucial, combined with acid suppression therapy.

Surgical intervention is reserved for complications such as perforation, uncontrolled bleeding, or obstruction. Procedures may include oversewing perforated ulcers, vagotomy to reduce acid production, or partial gastrectomy in severe cases. Endoscopic therapy can treat bleeding ulcers through cauterization, injection therapy, or clip placement.

Prognosis

With appropriate treatment, the prognosis for peptic ulcer disease is excellent. Most uncomplicated ulcers heal within 4-8 weeks of treatment, with cure rates exceeding 90% when H. pylori is successfully eradicated. Duodenal ulcers typically heal faster than gastric ulcers. Without treatment, ulcer recurrence rates approach 70-80% within one year, but successful H. pylori eradication reduces recurrence to less than 5%.

Mortality is low when ulcers are properly treated, with death rates less than 1% overall. However, complications significantly worsen prognosis, with bleeding ulcers carrying a 5-10% mortality rate and perforated ulcers having mortality rates of 10-40%, particularly in elderly patients. Most patients return to normal quality of life after successful treatment, though some may need to permanently avoid NSAIDs or require long-term acid suppression therapy.

Quality of life

Living with peptic ulcer disease requires several lifestyle adjustments to promote healing and prevent recurrence. Dietary modifications include eating smaller, more frequent meals to avoid overwhelming the digestive system and reducing intake of foods that increase acid production, such as coffee, alcohol, and highly spicy foods. While no specific “ulcer diet” is necessary, maintaining regular meal times and avoiding late-night eating can help manage symptoms.

Stress management plays an important role in overall digestive health. Techniques such as regular exercise, meditation, adequate sleep, and counseling can help reduce stress-related symptom flare-ups. Smoking cessation is crucial, as tobacco use significantly impairs ulcer healing and increases complication risk. Patients should maintain open communication with healthcare providers about pain management strategies that avoid NSAIDs when possible. Support groups and educational resources can help patients better understand their condition and connect with others facing similar challenges.

Pregnancy and fertility

Peptic ulcer disease generally does not affect fertility in men or women. However, pregnancy considerations are important for women with active ulcers or those requiring ongoing treatment. Many standard ulcer medications, including most proton pump inhibitors and antibiotics used for H. pylori eradication, are considered safe during pregnancy, though individual assessment is necessary.

Omeprazole and lansoprazole are preferred proton pump inhibitors during pregnancy. H. pylori eradication therapy may be delayed until after pregnancy if symptoms are manageable with acid suppression alone, as some antibiotic combinations carry potential risks. Pregnant women with ulcer symptoms should work closely with both their obstetrician and gastroenterologist to develop safe treatment plans. Untreated severe ulcers with complications may pose risks to both mother and baby, making appropriate treatment essential.

Children

Peptic ulcer disease is less common in children but does occur, with different patterns than adult disease. In children, H. pylori infection is less frequently associated with ulcers, and other causes such as medications, stress, or underlying medical conditions play larger roles. Symptoms in children may be less specific, including general abdominal pain, poor appetite, weight loss, or behavioral changes.

Diagnosis can be more challenging in pediatric patients, as endoscopy requires sedation and careful consideration of risks and benefits. Treatment approaches are similar to adults but require weight-based dosing and consideration of age-appropriate formulations. Family involvement in dietary management and medication compliance is crucial. Children with peptic ulcers may need academic accommodations during acute phases, including flexible meal times and access to medications during school hours.

When to see a doctor

Seek immediate emergency medical attention for severe abdominal pain that suddenly worsens, vomiting blood or material that looks like coffee grounds, passing black or tarry stools, or signs of severe blood loss such as dizziness, fainting, or rapid heartbeat. These symptoms may indicate life-threatening complications requiring urgent intervention.

Schedule routine medical evaluation for persistent stomach pain, especially if it follows a pattern of occurring between meals or at night, recurring indigestion or heartburn that doesn’t respond to over-the-counter treatments, unexplained weight loss, or persistent nausea and vomiting. Additionally, anyone taking NSAIDs regularly who develops stomach pain should consult a healthcare provider promptly, as should individuals with a family history of peptic ulcers who experience digestive symptoms.

Regional context

Limited specific data exists for peptic ulcer disease prevalence in the Caucasus region, though studies suggest H. pylori infection rates may be higher in some Eastern European and Central Asian populations, potentially affecting regional ulcer patterns. Healthcare infrastructure in Georgia, Armenia, and Azerbaijan varies, with urban centers generally having better access to endoscopic facilities and specialized gastroenterology services. Traditional dietary patterns in the region, including consumption of fermented foods and herbs, may influence both risk factors and symptom management approaches. GMJ welcomes contributions from regional researchers to build the evidence base for peptic ulcer disease in the Caucasus.

Research and clinical trials

Current research focuses on developing more effective H. pylori eradication regimens to combat increasing antibiotic resistance, with investigations into bismuth-based quadruple therapies and novel antibiotic combinations. Scientists are exploring the role of probiotics in preventing NSAID-related ulcers and supporting H. pylori treatment. Advanced endoscopic techniques for managing bleeding ulcers and minimally invasive surgical approaches continue to evolve.

Researchers are investigating the relationship between H. pylori and gastric cancer prevention, as well as personalized medicine approaches based on bacterial strain typing and antibiotic sensitivity testing. Novel acid suppression medications and cytoprotective agents are in development. Patients interested in clinical trials can search ClinicalTrials.gov for current studies investigating new treatments for peptic ulcer disease.

Frequently asked questions

Can stress really cause ulcers?

While stress alone doesn’t cause ulcers, it can worsen symptoms and may contribute to ulcer development when combined with other risk factors like H. pylori infection or NSAID use.

Do I need to avoid spicy foods permanently?

Spicy foods don’t cause ulcers, but they may irritate existing ulcers and worsen symptoms. Once your ulcer heals, you can likely resume eating spicy foods in moderation.

How long does treatment take to work?

Most people begin feeling better within a few days of starting treatment, though complete healing typically takes 4-8 weeks for uncomplicated ulcers.

Can ulcers come back after treatment?

Ulcer recurrence is rare (less than 5%) if H. pylori is successfully eradicated and risk factors are avoided. However, new ulcers can develop from continued NSAID use or reinfection with H. pylori.

Is surgery always necessary for bleeding ulcers?

No, many bleeding ulcers can be treated with endoscopic therapy or medications. Surgery is typically reserved for cases where other treatments fail or for severe complications like perforation.

Support and resources

– World Health Organization (WHO): https://www.who.int/
– American Gastroenterological Association: https://gastro.org/
– International Foundation for Gastrointestinal Disorders: https://iffgd.org/
– Helicobacter & Microbiota Study Group: https://www.helicobacter.org/
– National Institute of Diabetes and Digestive and Kidney Diseases: https://niddk.nih.gov/
– European Helicobacter and Microbiota Study Group: https://www.ehmsg.eu/

Related conditions

Gastroesophageal Reflux Disease (GERD) – Chronic acid reflux that can cause similar symptoms and may coexist with peptic ulcers.

Zollinger-Ellison Syndrome – Rare condition causing excessive acid production and multiple ulcers due to gastrin-secreting tumors.

Gastritis – Inflammation of the stomach lining that may progress to ulcer formation and shares many risk factors.

Crohn’s Disease – Inflammatory bowel disease that can cause ulcers throughout the digestive tract and increases peptic ulcer risk.

Helicobacter Pylori Infection – Bacterial infection that represents the leading cause of peptic ulcer disease worldwide.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, UpToDate, relevant EULAR/ACR/WHO guidelines. This article is for informational purposes only and does not constitute medical advice. Content licensed under CC BY 4.0.

Cite this page

GMJ News Desk. “Peptic Ulcer Disease.” GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/condition/peptic-ulcer-disease/

CC BY 4.0Licensed under CC BY 4.0. Free to share with attribution to GMJ News.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

Addison DiseaseCondition Adult-onset Still diseaseCondition Alzheimer DiseaseCondition Autosomal dominant polycystic kidney diseaseCondition Behcet DiseaseCondition
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Releases Rabies Post-Exposure Risk Assessment Tool for Clinical Practice

The UK Department of Health and Social Care has published a standardised…

UK Sets Minimum Age of 11 for Puberty Blocker Clinical Trial in Gender-Questioning Children

The UK has set a minimum age of 11 years for children…

Why Women Choose Freebirth: What Research Reveals About Unattended Childbirth

A growing number of women are choosing unattended childbirth, driven by desire…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Short bowel syndrome

By
Prof. Giorgi Pkhakadze
02/06/2026

Inflammatory Bowel Disease

By
Prof. Giorgi Pkhakadze
01/06/2026

Celiac Disease

By
Prof. Giorgi Pkhakadze
01/06/2026

GERD

By
Prof. Giorgi Pkhakadze
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up